Janus kinase 1 inhibitor
INCB054707
for patients with moderate‐to‐severe hidradenitis suppurativa: results from two phase
II
studies*
Mayo Clinic
British Journal of Dermatology | January 3, 2022 | Volume: 186 | Issue: 5 | Pages: 803-813
10.1111/bjd.20969
| PMID 34978076